(Q33826206)

29 July 2017

1 reference

title

Guidelines for stroke prevention in patients with atrial fibrillation (English)

1 reference

29 July 2017

1 reference

Howard PA

1

1 reference

29 July 2017

language of work or name

1 reference

1 December 1999

1 reference

29 July 2017

1 reference

29 July 2017

volume

58

1 reference

29 July 2017

issue

6

1 reference

29 July 2017

page(s)

997-1009

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199958060-00004

29 July 2017

exact match

0 references

cites work

Indobufen versus warfarin in the secondary prevention of major vascular events in nonrheumatic atrial fibrillation. SIFA (Studio Italiano Fibrillazione Atriale) Investigators.

1 reference

12 December 2020

Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly

1 reference

12 December 2020

Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications

1 reference

12 December 2020

Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals

1 reference

12 December 2020

Atrial fibrillation and stroke: new ideas, persisting dilemmas

1 reference

12 December 2020

Risk factors for intracranial hemorrhage in outpatients taking warfarin

1 reference

12 December 2020

Guidelines for medical treatment for stroke prevention. American College of Physicians

1 reference

12 December 2020

Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators

1 reference

12 December 2020

Interaction of dietary factors with oral anticoagulants: review and applications

1 reference

12 December 2020

Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study. The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators

1 reference

12 December 2020

Recent national patterns of warfarin use in atrial fibrillation

1 reference

12 December 2020

The efficacy of aspirin in patients with atrial fibrillation. Analysis of pooled data from 3 randomized trials. The Atrial Fibrillation Investigators

1 reference

12 December 2020

Antithrombotic therapy in atrial fibrillation

1 reference

12 December 2020

National patterns of warfarin use in atrial fibrillation.

1 reference

12 December 2020

Canadian atrial fibrillation anticoaguiation (CAFA) study

1 reference

12 December 2020

Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

1 reference

12 December 2020

Ischemic stroke in patients with atrial fibrillation: effect of aspirin according to stroke mechanism. Stroke Prevention in Atrial Fibrillation Investigators.

1 reference

12 December 2020

Prevention of stroke in patients with nonvalvular atrial fibrillation

1 reference

12 December 2020

Cost-effectiveness of anticoagulation in nonrheumatic atrial fibrillation in the primary prevention of ischemic stroke.

1 reference

12 December 2020

Clinically significant drug interactions with the oral anticoagulants

1 reference

12 December 2020

Optimal oral anticoagulant therapy in patients with mechanical heart valves.

1 reference

12 December 2020

The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation

1 reference

12 December 2020

Anticoagulation in atrial fibrillation. Does efficacy in clinical trials translate into effectiveness in practice?

1 reference

12 December 2020

From clinical trials to clinical practice: oral anticoagulation among patients with non-rheumatic, atrial fibrillation

1 reference

12 December 2020

Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation

1 reference

12 December 2020

Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia

1 reference

12 December 2020

Stroke Prevention in Atrial Fibrillation II Study

1 reference

12 December 2020

European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke

1 reference

12 December 2020

Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial

1 reference

12 December 2020

Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group

1 reference

12 December 2020

Antiplatelet therapy to prevent stroke: risk of brain hemorrhage and efficacy in atrial fibrillation.

1 reference

12 December 2020

Stroke Prevention in Atrial Fibrillation Study. Final results

1 reference

12 December 2020

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

1 reference

12 December 2020

ASHP therapeutic position statement on antithrombotic therapy in chronic atrial fibrillation. American Society of Health-System Pharmacists

1 reference

12 December 2020

Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group

1 reference

12 December 2020

Differential effect of aspirin versus warfarin on clinical stroke types in patients with atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators

1 reference

12 December 2020

Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators

1 reference

12 December 2020

Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators

1 reference

12 December 2020

Interactions of warfarin with drugs and food

1 reference

12 December 2020

An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation.

1 reference

12 December 2020

Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapy

1 reference

12 December 2020

Fixed minidose warfarin and aspirin alone and in combination vs adjusted-dose warfarin for stroke prevention in atrial fibrillation: Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation Study.

1 reference

12 December 2020

Atrial fibrillation and stroke. Three new studies, three remaining questions

1 reference

12 December 2020

Atrial fibrillation follow-up investigation of rhythm management -- the AFFIRM study design. The Planning and Steering Committees of the AFFIRM study for the NHLBI AFFIRM investigators

1 reference

12 December 2020

Cost effectiveness of primary stroke prevention in atrial fibrillation: Swedish national perspective

1 reference

12 December 2020

Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials

1 reference

12 December 2020

Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study

1 reference

12 December 2020

10.2165/00003495-199958060-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

29 July 2017

1016676931

0 references

Fatcat ID

release_3vtaodh27rallffgkcjtj3twey

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3vtaodh27rallffgkcjtj3twey

24 November 2022

mapped directly with Wikidata item

1 reference